As of December 2024, Amicus Therapeutics has a market cap of $2.85B. This makes Amicus Therapeutics the world's 4107th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $4.02B | -3.49% |
2023 | $4.16B | 16.22% |
2022 | $3.58B | 5.71% |
2021 | $3.39B | -49.98% |
2020 | $6.77B | 137.06% |
2019 | $2.86B | 1.67% |
2018 | $2.81B | -33.43% |
2017 | $4.22B | 189.54% |
2016 | $1.46B | -48.76% |
2015 | $2.84B | 16.59% |
2014 | $2.44B | 254.04% |
2013 | $689.13M | -12.31% |
2012 | $785.90M | -22.09% |
2011 | $1.01B | -26.81% |
2010 | $1.38B | 18.39% |
2009 | $1.16B | -50.25% |
2008 | $2.34B | -25.77% |
2007 | $3.15B | - |